检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.
研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abstract 5727: ISM9682A, a novel and potent KIF18A inhibitor, shows robust antitumor effects against chromosomally unstable cancers
Jie Zhang, Feng Gao, Wei Zhu, Chenxi Xu, Xiaoyu Ding, Jing Shang, Junwen Qiao, Shan Chen,Xin Cai,Xiao Ding, Supriya Bavadekar, Sujata Rao,
Cancer Researchno. 6_Supplement (2024): 5727-5727
引用0浏览0引用
0
0
Abstract PO2-05-08: ISM5043, a novel, selective KAT6 inhibitor for the treatment of advanced and refractory ER+ breast cancer
Xin Cai, Xin Cheng, Luoheng Qin, Man Zhang, Junwen Qiao, Supriya Bavadekar, Sujata Rao,Feng Ren
Cancer Researchno. 9_Supplement (2024): PO2-05
引用0浏览0引用
0
0
Abstract 5582: Discovery and preclinical characterization of ISM8001, a covalent and selective FGFR2/FGFR3 dual inhibitor with strong monotherapy anti-tumor activity against advanced solid tumors
Yihong Zhang, Yazhou Wang,Xin Cai, Jinxin Liu, Hui Cui, Junwen Qiao, Xiaoxia Lin,Xiao Ding, Supriya Bavadekar, Sujata Rao, Man Zhang,Feng Ren,
Cancer Researchno. 6_Supplement (2024): 5582-5582
引用0浏览0引用
0
0
Discovery of macrocyclic CDK2/4/6 inhibitors with improved potency and DMPK properties through a highly efficient macrocyclic drug design platform
Fanye Meng, Jinxin Liu, Zhongying Cao, Jiaojiao Yu, Barbara Steurer, Yilin Yang, Yazhou Wang,Xin Cai, Man Zhang,Feng Ren,Alex Aliper,Xiao Ding,
Bioorganic Chemistry (2024): 107285-107285
引用0浏览0WOS引用
0
0
Abstract 502: ISM3091, a novel selective USP1 inhibitor as a targeted anticancer therapy
Yangguang Li,Jianping Wu, Jinxin Liu,Luoheng Qin,Xin Cai, Junwen Qiao, Ling Wang, Sujata Rao,Feng Ren,Alex Zhavoronkov
Cancer Researchno. 7_Supplement (2023): 502-502
引用0浏览0引用
0
0
ISM3091, a novel selective USP1 inhibitor as a targeted anticancer therapy
Yangguang Li, Jianping Wu, Jinxin Liu, Luoheng Qin,Xin Cai, Junwen Qiao,Ling Wang, Sujata Rao,Feng Ren,Alex Zhavoronkov
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
Abstract 4989: Discovery and evaluation of ISM6466A, a novel covalent CDK12 inhibitor for the treatment of cancer
Lihua Min, Huichao Lu, Yihong Zhang, Jianping Wu,Xin Cai, Ming–Hua Zheng,Hui Chen, Junwen Qiao,Xiao Ding, Sujata Rao,Feng Ren,Alex Zhavoronkov
Cancer Researchno. 7_Supplement (2023): 4989-4989
引用0浏览0引用
0
0
Abstract 1855: Targeting DGKA for immuno-oncology therapy: ISM4312A, a novel DGKA inhibitor with robust anti-tumor activity
Deheng Sun, Huiqing Lu, Huaxing Yu, Wei Feng, Mike Korzinkin,Xin Cai,Xiao Ding, Sujata Rao,Feng Ren,Alex Zhavoronkov
Cancer Researchno. 7_Supplement (2023): 1855-1855
引用0浏览0引用
0
0
Discovery and evaluation of ISM6466A, a novel covalent CDK12 inhibitor for the treatment of cancer
Lihua Min,Hongfu Lu, Yihong Zhang, Jianping Wu,Xin Cai, Min Zheng, Hui Cui, Junwen Qiao,Xiao Ding, Sujata Rao,Feng Ren,Alex Zhavoronkov
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
Abstract 503: ISM3412, a novel and selective MAT2A inhibitor for the treatment of cancer
Qing‐Yuan Meng,Xiao Ding, Xiaosong Liu, Hailong Wang, Ling Wang, Junwen Qiao, Hua Cao, Yushu Yin, Congcong Zhu, Xing Lü,Xin Cai,Yuanyuan Xu,
Cancer Researchno. 7_Supplement (2023): 503-503
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn